2004
DOI: 10.1016/j.ejphar.2004.07.044
|View full text |Cite
|
Sign up to set email alerts
|

Nerve growth factor and its receptors in asthma and inflammation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
87
2

Year Published

2007
2007
2018
2018

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 90 publications
(89 citation statements)
references
References 174 publications
0
87
2
Order By: Relevance
“…This raises the possibility that reduced neurotrophin expression following SIV infection might be a consequence of denervation, rather than a cause, since neurotrophins may derive from both immune and neural sources (Kuruvilla, et al, 2004;Bronzetti, et al, 2006;Edling, et al, 2004;Frossard, et al, 2004;Levi-Montalcini, 1987). However, two findings argue against the hypothesis that changes in neurotrophin expression are solely a consequence of denervation.…”
Section: Discussioncontrasting
confidence: 45%
See 1 more Smart Citation
“…This raises the possibility that reduced neurotrophin expression following SIV infection might be a consequence of denervation, rather than a cause, since neurotrophins may derive from both immune and neural sources (Kuruvilla, et al, 2004;Bronzetti, et al, 2006;Edling, et al, 2004;Frossard, et al, 2004;Levi-Montalcini, 1987). However, two findings argue against the hypothesis that changes in neurotrophin expression are solely a consequence of denervation.…”
Section: Discussioncontrasting
confidence: 45%
“…Members of the neurotrophin family, including nerve growth factor (NGF), brain derived neurotrophic factor (BDNF), neurotrophin-3 (NT3) and neurotrophin-4/5 (NT4), are critical in shaping patterns and density of innervation, both centrally and in the periphery. NGF was first characterized as an essential factor for neuronal development and survival (Levi-Montalcini, 1987) and is expressed in a wide range of neuronal and non-neuronal celltypes (Levi-Montalcini, 1987;Frossard, et al, 2004). Target-derived NGF is essential for guiding developing sympathetic neurons to peripheral organs (Kuruvilla, et al, 2004).…”
Section: Introductionmentioning
confidence: 99%
“…45 As described above, several studies suggest that NGF can activate immunocompetent cells such as lymphocytes, macrophages and granulocytes. [27][28][29][30][31][32][33][34][35][36][37][38][39] Although several reports show the relationship between VEGF and inflammation, 46,47 to our knowledge there is no compelling evidence that VEGF directly activates immunocompetent cells. This difference in pro-inflammatory properties of growth factors might be one of the reasons for the discrepancy in transplant outcome.…”
Section: Do Not Distributementioning
confidence: 99%
“…The reason for this unexpected result remains unclear. Several studies have shown that NGF seems to have not just an islet regulatory role [19][20][21][22] but also pro-inflammatory properties, [27][28][29][30] mediating effects such as lymphocyte [31][32][33][34][35] and macrophage activation, 32,36,37 eosinophil chemotaxis, 38 and mast cell survival and degranulation. 39 One possible explanation for the discrepancy in our results is that NGF-treated islets may stimulate immunocompetent cells after intraportal islet transplantation.…”
Section: Do Not Distributementioning
confidence: 99%
“…NGF has been shown to synergize with granulocyte-macrophage CSF (GM-CSF) to promote human basophilic cells differentiation (14) and synergize with stem cell factor to support hemopoietic stem cell development (15,16). NGF was found to be increased during inflammatory responses (17), autoimmune disorders (18,19), allergic diseases (20) and stress (21). Thus, NGF is also regarded as an important factor involved in the immune responses and pathogenesis of autoimmune diseases.…”
mentioning
confidence: 99%